• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Atrion Reports Second Quarter 2024 Results

    8/8/24 6:00:00 PM ET
    $ATRI
    Medical/Dental Instruments
    Health Care
    Get the next $ATRI alert in real time by email

    ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the second quarter ended June 30, 2024.

    Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 million from the comparable 2023 period, and net income was $0.4 million, down $6.2 million from the same period in 2023. Operating income was significantly impacted by the accrual of $5.0 million in acquisition-related expenses discussed below. Second quarter 2024 diluted earnings per share were $0.23 compared to $3.73 for the second quarter of 2023.

    Commenting on the results for the second quarter of 2024 compared to the prior year period, David Battat, President and CEO, stated, "We were pleased to see strong revenue growth of 11%. Adjusting for the accrual of expenses relating to the merger with Nordson Corporation announced May 28, 2024, operating income was $5.5 million, down 25% from the prior year period. Our MPS consoles showed particularly strong growth, with sales up 22% and MPS disposables sales up 21%. We saw continued recovery in our fluid delivery products, with certain product families showing double-digit revenue increases compared to the prior year period. We continued to halt some fluid delivery production lines to reduce inventories accumulated as the result of the supply chain disruptions in 2023. While this halt resulted in under-absorption of overhead and negatively impacted operating income, the value of inventories declined 10% from the first to the second quarters of this year and are 18% lower than they were December 31, 2023."

    Mr. Battat concluded, "As of June 30, 2024, cash and short- and long-term investments totaled $23.2 million. We remain debt free."

    Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com.

    Contact:Cindy Ferguson

    Vice President and Chief Financial Officer

    (972) 390-9800

     

    ATRION CORPORATION

    UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

    (In thousands, except per share data)
     
     Three Months Ended

    June 30,
     Six Months Ended

    June 30,
      2024   2023   2024   2023 
    Revenues$48,773  $43,838  $96,107  $83,831 
    Cost of goods sold 32,926   26,584   67,909   51,496 
    Gross profit 15,847   17,254   28,198   32,335 
    Operating expenses 15,313   9,875   24,522   20,486 
    Operating income 534   7,379   3,676   11,849 
            
    Interest and dividend income  388    127    544    367 
    Other investment income (loss)  (542)   98    (651)   (623)
    Other income  23    29    37    39 
    Interest expense  --    (27)   --    (27)
    Income before income taxes 403   7,606   3,606   11,605 
    Income tax provision (1)  (1,043)  (412)  (1,557)
    Net income $402  $6,563  $3,194  $10,048 
            
    Income per basic share$0.23  $3.73  $1.81  $5.71 
            
    Weighted average basic shares outstanding 1,761   1,760   1,761   1,761 
            
            
    Income per diluted share$0.23  $3.73  $1.81  $5.70 
            
    Weighted average diluted shares outstanding 1,763   1,761   1,762   1,762 



    ATRION CORPORATION

    CONSOLIDATED BALANCE SHEETS

    (In thousands)
     
     June 30, Dec 31,
    ASSETS2024 2023
     (Unaudited)  
    Current assets:   
    Cash and cash equivalents$11,462 $3,565
    Short-term investments 6,124  2,691
    Total cash and short-term investments 17,586  6,256
    Accounts receivable 26,555  23,029
    Inventories 67,641  82,307
    Prepaid expenses and other 7,480  3,173
    Total current assets 119,262  114,765


    Long-term investments
     5,624  8,165


    Property, plant and equipment, net
     122,905  125,347
    Other assets 12,563  12,548
        
     $260,354 $260,825
        
        
    LIABILITIES AND STOCKHOLDERS' EQUITY   
        
    Current liabilities 17,537  12,621
    Other non-current liabilities 3,944  5,315
    Stockholders' equity 238,873  242,889
        
     $260,354 $260,825



    ATRION CORPORATION

    NON-GAAP FINANCIAL INFORMATION

    (In thousands)
     

    This release includes a reference to non-GAAP operating income that excludes merger-related expenses accrued in the second quarter of 2024. This financial measure is not prepared in accordance with GAAP. The operating income excluding the merger accrual is calculated by increasing operating income by the amount of the merger-related expenses.

    We believe that this non-GAAP measure provides insight into our operating income performance. However, this non-GAAP financial measure may not be comparable to similarly titled non-GAAP financial measures used by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for GAAP financial measures. and are supplemental to the comparable GAAP measures.

    Reconciliation to the most directly comparable GAAP measure is provided in the table below.

     Three Months Ended

    June 30,
       
     2024 2023 Change 
    Revenues$ 48,773 $43,838  11% 
    Cost of goods sold 32,926  26,584   
    Gross profit 15,847  17,254   
           
    Operating income 534  7,379   
    Add: merger accrual 5,000  -   
    Operating income excluding merger accrual 5,534  7,379  (25%) 


    Primary Logo

    Get the next $ATRI alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ATRI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATRI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Atrion Reports Second Quarter 2024 Results

      ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 million from the comparable 2023 period, and net income was $0.4 million, down $6.2 million from the same period in 2023. Operating income was significantly impacted by the accrual of $5.0 million in acquisition-related expenses discussed below. Second quarter 2024 diluted earnings per share were $0.23 compared to $3.73 for the second quarter of 20

      8/8/24 6:00:00 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Atrion Corporation Enters Into Merger Agreement with Nordson Corporation

      ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion's 2023 EBITDA, and the $460 per share price represents a 15% premium to Atrion's 90-day average daily volume-weighted average stock price. The proposed transaction was unanimously approved by the Boards of Directors of Atrion

      5/28/24 7:24:38 AM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies

      Expands Nordson MEDICAL's total addressable market Highly complementary with Nordson's customer base and core competencies Broadens Nordson's exposure to higher-growth and stable medical end markets Nordson to host investor call at 8:30 a.m. ET today Nordson Corporation (NASDAQ:NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (NASDAQ:ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. Th

      5/28/24 7:00:00 AM ET
      $ATRI
      $NDSN
      Medical/Dental Instruments
      Health Care
      Industrial Machinery/Components
      Industrials

    $ATRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Athey Preston G bought $95,904 worth of shares (300 units at $319.68), increasing direct ownership by 28% to 1,368 units (SEC Form 4)

      4 - ATRION CORP (0000701288) (Issuer)

      12/1/23 2:53:55 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Battat David A bought $90,000 worth of shares (300 units at $300.00), increasing direct ownership by 0.77% to 39,400 units (SEC Form 4)

      4 - ATRION CORP (0000701288) (Issuer)

      11/16/23 2:49:33 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care

    $ATRI
    SEC Filings

    See more
    • SEC Form 15-12G filed by Atrion Corporation

      15-12G - ATRION CORP (0000701288) (Filer)

      9/3/24 9:11:57 AM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 POS filed by Atrion Corporation

      S-8 POS - ATRION CORP (0000701288) (Filer)

      8/21/24 9:24:19 AM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 POS filed by Atrion Corporation

      S-8 POS - ATRION CORP (0000701288) (Filer)

      8/21/24 9:23:12 AM ET
      $ATRI
      Medical/Dental Instruments
      Health Care

    $ATRI
    Financials

    Live finance-specific insights

    See more
    • Atrion Reports Second Quarter 2024 Results

      ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 million from the comparable 2023 period, and net income was $0.4 million, down $6.2 million from the same period in 2023. Operating income was significantly impacted by the accrual of $5.0 million in acquisition-related expenses discussed below. Second quarter 2024 diluted earnings per share were $0.23 compared to $3.73 for the second quarter of 20

      8/8/24 6:00:00 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies

      Expands Nordson MEDICAL's total addressable market Highly complementary with Nordson's customer base and core competencies Broadens Nordson's exposure to higher-growth and stable medical end markets Nordson to host investor call at 8:30 a.m. ET today Nordson Corporation (NASDAQ:NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (NASDAQ:ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. Th

      5/28/24 7:00:00 AM ET
      $ATRI
      $NDSN
      Medical/Dental Instruments
      Health Care
      Industrial Machinery/Components
      Industrials
    • Atrion Corporation Declares Quarterly Cash Dividend

      ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact: Cindy FergusonVice President and Chief Financial Officer(972) 390-9800         

      5/21/24 4:30:00 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care

    $ATRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Stupp John P Jr returned $69,149,960 worth of shares to the company (150,326 units at $460.00), closing all direct ownership in the company (SEC Form 4)

      4 - ATRION CORP (0000701288) (Issuer)

      8/21/24 5:00:44 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Director Spaulding Ronald Nicholas returned $1,231,880 worth of shares to the company (2,678 units at $460.00), closing all direct ownership in the company (SEC Form 4)

      4 - ATRION CORP (0000701288) (Issuer)

      8/21/24 4:30:30 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Director Athey Preston G returned $629,280 worth of shares to the company (1,368 units at $460.00), closing all direct ownership in the company (SEC Form 4)

      4 - ATRION CORP (0000701288) (Issuer)

      8/21/24 4:19:38 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care

    $ATRI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Atrion Corporation

      SC 13G/A - ATRION CORP (0000701288) (Subject)

      9/9/24 4:05:03 PM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Atrion Corporation

      SC 13D/A - ATRION CORP (0000701288) (Subject)

      8/22/24 6:05:08 AM ET
      $ATRI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Atrion Corporation

      SC 13D/A - ATRION CORP (0000701288) (Subject)

      8/22/24 6:04:56 AM ET
      $ATRI
      Medical/Dental Instruments
      Health Care